Findings

What do systematic reviews say?

29 questions · 34 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 5.9%GRADE not reported 0 · 0%Very low 13 · 38.2%Low 13 · 38.2%Moderate 4 · 11.8%High 2 · 5.9%

Mindfulness‐based interventions (MBIs) vs no treatment

Continuous abstinence rate at

2 findings from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 112 participants
Very low
Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 112 participants
Very low

Mindfulness‐based interventions (MBIs) vs other treatments

Continuous abstinence rate at

2 findings from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 286 participants
Very low
Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 286 participants
Very low

Mindfulness‐based interventions (MBIs) vs other treatments

Percentage days with substance use at

2 findings from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 523 participants
Low
Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 409 participants
Low

Mindfulness‐based interventions (MBIs) vs other treatments

Consumed amount at post‐treatment Lower SMD favors MBI

1 finding from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Very low

Mindfulness‐based interventions (MBIs) vs other treatments

Craving

2 findings from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 971 participants
Very low
Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 415 participants
Very low

Mindfulness‐based interventions (MBIs) vs other treatments

Secondary outcome: acceptability of treatment

1 finding from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
14 studies · 1531 participants
High

Mindfulness‐based interventions (MBIs) vs no treatment

Percentage days with substance use at

2 findings from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 248 participants
Very low
Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 167 participants
Very low

Mindfulness‐based interventions (MBIs) vs no treatment

Consumed amount at post‐treatment Lower SMD favors MBI

1 finding from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 221 participants
Very low

Mindfulness‐based interventions (MBIs) vs no treatment

Consumed amount at

1 finding from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 142 participants
Very low

Mindfulness‐based interventions (MBIs) vs no treatment

Craving

1 finding from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 128 participants
Very low

Mindfulness‐based interventions (MBIs) vs no treatment

Secondary outcome: acceptability of treatment

1 finding from 1 review

Mindfulness‐based interventions for substance use disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
21 studies · 1087 participants
High

Mindfulness‐based interventions (MBIs) vs active comparators

Cardiovascular events · people at high risk of or withcardiovascular disease

The review found no eligible studies for this question.

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mindfulness‐based interventions (MBIs) vs non‐active comparators

Clinical CVD events (CVD mortality and non‐fatal MI) · people at high risk of or withcardiovascular disease

It is very uncertain whether mindfulness‐based interventions (MBIs) changes clinical CVD events (CVD mortality and non‐fatal MI) compared with non‐active comparators (very low certainty).

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
RR 0.94 [0.37, 2.42]
1 study · 110 participants
Very low

Mindfulness‐based interventions (MBIs) vs non‐active comparators

Systolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 379 participants
Low

Mindfulness‐based interventions (MBIs) vs non‐active comparators

Diastolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 379 participants
Low

Mindfulness‐based interventions (MBIs) vs non‐active comparators

Anxiety · people at high risk of or withcardiovascular disease

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 533 participants
Low

Mindfulness‐based interventions (MBIs) vs non‐active comparators

Depression, change from baseline · people at high risk of or withcardiovascular disease

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
no estimate extracted
15 studies · 912 participants
Low

Mindfulness‐based interventions (MBIs) vs non‐active comparators

Perceived stress, change from baseline · people at high risk of or withcardiovascular disease

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 708 participants
Low

Mindfulness‐based interventions (MBIs) vs non‐active comparators

General well‐being · people at high risk of or withcardiovascular disease

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 198 participants
Moderate

Mindfulness‐based interventions (MBIs) vs non‐active comparators

Adverse events · people at high risk of or withcardiovascular disease

Mindfulness‐based interventions (MBIs) showed no clear difference in adverse events compared with non‐active comparators (low certainty).

1 finding from 1 review

Meditation for the primary and secondary prevention of cardiovascular disease 2024 · Cochrane Headline outcomes only
RR 5 [0.27, 91.52]
1 study · 18 participants
Low